Related Experiment Video

Updated: May 14, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
12:24

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

Myocardial radionuclide imaging in patients with hypertrophic cardiomyopathy

Min Cai1, Yue-Qin Tian, Zuo-Xiang He

  • 1Department of Nuclear Medicine, Cardiovascular Institute, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, 167, Bei Li Shi Lu Beijing 100037, China.

Nuclear Medicine Communications
|January 30, 2013
PubMed

Insights

Myocardial radionuclide imaging offers valuable insights into hypertrophic cardiomyopathy (HCM), aiding in diagnosis and evaluating treatment effectiveness. This technique explores the complex relationship between structural, pathological, and functional changes in HCM patients.

Area of Science:

  • Cardiology
  • Medical Imaging

Background:

  • Hypertrophic cardiomyopathy (HCM) is a primary, familial cardiac disorder with diverse clinical presentations.
  • Electrocardiogram (ECG) and cardiovascular MRI are key diagnostic tools for HCM.
  • Understanding the interplay of morphological, pathophysiological, and functional changes in HCM is crucial.

Purpose of the Study:

  • To highlight the value of myocardial radionuclide imaging in the comprehensive evaluation of hypertrophic cardiomyopathy.
  • To explore the detailed information provided by radionuclide imaging on myocardial perfusion, metabolism, and neurological function.
  • To assess the utility of radionuclide imaging in evaluating transcoronary ethanol septal ablation and prognosis in HCM.

Main Methods:

  • Utilized myocardial radionuclide imaging to assess myocardial perfusion, metabolism, and neurological function.
  • Correlated imaging findings with morphological, pathophysiological, and functional changes in HCM.
  • Evaluated the impact of transcoronary ethanol septal ablation using radionuclide imaging.

Main Results:

  • Myocardial radionuclide imaging provides detailed insights into myocardial perfusion, metabolism, and neurological function in HCM.
  • The technique effectively explores the inter-relationship between structural, pathological, and functional aspects of HCM.
  • Radionuclide imaging is useful for assessing the outcomes of transcoronary ethanol septal ablation and patient prognosis.

Conclusions:

  • Myocardial radionuclide imaging is an important tool for the comprehensive evaluation of hypertrophic cardiomyopathy.
  • It offers detailed information crucial for understanding HCM's complex pathophysiology.
  • This imaging modality aids in treatment assessment and prognosis prediction for HCM patients.

More Related Videos

High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals11:09

High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals

Published on: December 16, 2022

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...